Your Messages Inbox
Your Article Summary
See Latest ArticlesFDA Approves Alcons AcrySof(R) IQ ReSTOR(R) +3.0 D Intraocular Lens
Alcon, 03/30/09
Alcon, Inc. (NYSE: ACL), the world's leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its +3.0 diopter add power AcrySof(R) IQ ReSTOR(R) IOL. This new lens, which was introduced in many major markets outside the United States earlier this year, is now approved in the U.S. for cataract surgery in patients with presbyopia. This lens is another technology advancement for the AcrySof(R) IQ ReSTOR(R) platform, which has been the number one choice of surgeons to correct presbyopia in cataract patients since it was introduced in 2005.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor